Clinical and Laboratory
She has a large clinical practice, specialising in thrombosis and haemostasis and obstetric haematology. She leads on the management of thrombosis within GSTT. She set up the award-winning “Thrombosis” app – thrombosis management in elegant algorithms.
Her laboratory work includes sitting on the board of Viapath LLP and leading in all aspects of haematological laboratory work.
Research and Development
She runs a research group with over 330 peer-reviewed publications to her name and won the BMJ Research paper of the year 2011 with the CRASH-2 team.
National and International Work
She is a recognised national and international expert in thrombosis and bleeding disorders.
She sits on the editorial boards of the British Journal for Haematology, Journal of Thrombosis and Haemostasis, Lupus, and Seminars in Thrombosis and Haemostasis.
She is a chair in the ISTH (International Society for Thrombosis and Haemostasis) Perioperative Haemostasis group. She lectures at 40+ national and international meetings annually.
She works frequently with NICE; is on their Expert Panel, and was involved in writing multiple NICE guidance on thrombosis and thromboprophylaxis.
She set up the BHS Obstetric Haematology Group with Dr Sue Pavord 12 years ago and this has flourished with a twice-yearly well-attended meeting. She credits “The Manual of Obstetric Haematology” with Dr Pavord.
She is chair of the British Society for Haematology External Affairs committee.
She is honorary president of “VTE Ireland” – the Irish platform to increase understanding of VTE and campaign for mandating venous thromboembolism (VTE) risk assessment in Irish hospitals.
In recognition of her work in obstetric haematology, she is the first ambassador for the antipodean organisation HOW (Haematologists in Obstetric and Woman's health).
She led on behalf of the UK thrombosis and haemostasis community in a successful bid to bring the ISTH meeting (10-12,000 delegates) to the Excel Centre, London in 2022.
Thrombosis UK and World Thrombosis Day
In 2002 she founded and is now Medical Director of the thrombosis charity, ‘Lifeblood: the thrombosis charity’, which rebranded as Thrombosis UK. It aims to increase awareness of thrombosis especially venous thromboembolism (VTE), to campaign for better care and lastly to fund research in VTE. She is very proud that it is now a medium-sized charity with funding mainly from the public and it was Health Charity of the Year 2010 for its campaigning in the mandating of VTE risk assessment in UK hospitals to reduce the rate of hospital-acquired thrombosis: this has led to a 9% reduction on death due to VTE in England.
She is a founding member of a team, sponsored by the ISTH, organising “World Thrombosis Day”. This aims to increase the global awareness of thrombosis especially VTE She leads on World Thrombosis Day campaigning to persuade the World Health Organisation to take VTE risk assessment to all hospital globally.Back to speakers